Acute cardiovascular effects of OPC-18790 in patients with congestive heart failure: Time- and dose-dependence analysis based on pressure-volume relations

Circulation

Volumn 93, Issue 3, 1996, Pages 474-483

  Feldman, Marc D ^b   Pak, Peter H ^b   Wu, Clarence C ^b   Haber, Howard L ^b   Heesch, Christian M ^b   Bergin, James D ^b   Powers, Eric R ^b   Cowart, T Douglas ^b   Johnson, William ^b   Feldman, Arthur M ^b   Kass, David A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

cardiomyopathy; heart failure; hemodynamics; inotropic agents; quinolinone

Indexed keywords

LUSITROPIC; QUINOLINE DERIVATIVE; TOBORINONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DOSE RESPONSE; ELASTICITY; FEMALE; HEART FAILURE; HEART VENTRICLE PRESSURE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; VEIN DILATATION;

EID: 9044246667     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.3.474     Document Type: Article

References (54)

1. Ohnishi A, Toyoki T, Ohno T, Takeshige Y, Fujita T, Kodama K, Mishima M, Hirayama A, Kitani M, Miyamoto O, Odomi M, Tanaka P. Pharmacokinetics and pharmacodynamics of intravenous OPC-18790 in humans: a novel nonglycosidic inotropic agent. J Clin Pharmacol. 1994;34:176-183.
2. Hosokawa T, Mori T, Fujiki H, Kinoshita S, Takemoto K, Imaizumi T, Noda T, Ohura M, Tominaga M, Yabuuchi Y. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action. Heart Vessels. 1992;7:66-75.
3. Fujioka T, Teramoto S, Mori T, Hosokawa T, Sumida T, Tominaga M, Yabuuchi Y. Novel positive inotropic agents: synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2(1H) -quinolinone derivatives. J Med Chem. 1992;35:3607-3612.
4. Wu Z, Awaji T, Abe H, Motomura S, Hashimoto K. Effects of OPC-18790, a new positive inotropic agent, on canine ventricular arrhythmias. Jpn J Pharmacol. 1993;63:399-404.
5. Hoit DB, Burwig S, Eppert D, Bhat G, Walsh RA. Effects of a novel inotropic agent (OPC-18790) on systolic and diastolic function in patients with severe heart failure. Am Heart J. 1994;128:1156-1163.
6. Abraham WT, Lowes BD, White M, Ferguson DA, Scheffel CA, Wolfel EE, Lindenfeld J, Bristow MR. Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure. J Card Failure. 1995;1:57-62.
7. Endoh M, Kawabata Y, Katano Y, Norota I. Effects of a novel cardiotonic agent (±)-6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-Quinolinone (OPC-18790) on contractile force, cyclic AMP level, and aequorin light transients in dog ventricular myocardium. J Cardiovasc Pharmacol. 1994;23:723-730.
8. Bell AS, Campbell SF, Morris DS, Roberts DA, Stefaniak MH. 2(1H)-quinolinones with cardiac stimulant activity, III: synthesis and biological properties of 6-imidazol-1-yl derivatives. J Med Chem. 1989;32:1552-1558.
9. Iijima T, Taira N. Membrane current changes responsible for the positive inotropic effect of OPC-8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heart. J Pharmacol Exp Ther. 1987;240:657-662.
10. Kurachi Y, Asano Y, Ho H, Sugimoto T. Voltage-dependent inhibition of the delayed outward potassium current by OPC-8490, a novel positive inotropic agent, in isolated atrial myocytes of guinea-pig heart. Naunyn Schmiedebergs Arch Pharmacol. 1990;341: 324-330.
11. Cody RJ, Leier CV, Bristow MR, Fifer MA, Binkley PF, Mass GJ, Starling RC, Abraham WT, Lowes BD, Dec GW, Semigran MJ, Cowart TD. OPC-18790 produces titratable hemodynamic benefit in hospitalized patients with severe congestive heart failure. Circulation. 1993;88(pt 2):I-300. Abstract.
12. Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation. 1987;75:331-339.
13. Roden RL, Mitchusson KD, Skerl L, Bristow MR. Inotropic action of OPC-18790 in the isolated failing and nonfailing human heart. J Am Coll Cardiol. 1993;21:365A. Abstract.
14. Kass DA, Midei M, Graves W, Maughan WL. Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn. 1988;15:192-202.
15. Kitani M, Miyamoto G, Odomi M. Stereoselectivc high-performance liquid chromatographic assay for the determination of OPC-18790 enantiomers in human plasma and urine. J Chromatogr B Biomed Appl. 1993;620:97-104.
16. Baan J, Van der Velde ET, de Brun HG, Smeenk GJ, Koops J, van Dijk AD, Temmerman D, Senden J, Buis B. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation. 1984;70:812-823.
17. Odake M, Takeuchi M, Takaoka H, Hata K, Hayashi Y, Yokoyama M. Determination of left ventricular volume using a conductance catheter in the diseased human heart. Eur Heart J. 1992;13(suppl E):22-27.
18. Kennedy JW, Trenholme SE, Kasser IS. Left ventricular volume and mass from single-plane cineangiocardiogram. Am Heart J. 1970; 80:343-352.
19. Brogan WC III, Glamann B, Lange RA, Hillis LD. Comparison of single and biplane ventriculography for determination of left ventricular volume and ejection fraction. Am J Cardiol. 1992;69: 1079-1082.
20. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol. 1983;245:H773-H780.
21. Kelly RP, Ting CT, Yang TM, Maughan WL, Chang MS, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992;86:513-521.
22. Suga H, Sagawa K. Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res. 1974;35:117-128.
23. Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, Sagawa K. Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation. 1987;76: 1422-1436.
24. Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW, Olsen CO, Tyson GS, Sabiston DC, Rankin JS. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation. 1985;71:994-1009.
25. Sharir T, Haber H, Feldman M, Marmor A, Becker LC, Kass DA. Ventricular systolic assessment in patients with dilated cardiomyopathy by preload-adjusted maximal power: validation and noninvasive application. Circulation. 1994;89:2045-2053.
26. Asanoi H, Sasayama S, Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circ Res. 1989;65:483-493.
27. Sunagawa K, Maughan WL, Sagawa K. Optimal arterial resistance for maximal stroke work studied in isolated canine ventricle. Circ Res. 1985;56:586-595.
28. de Tombe PP, Jones S, Burkhoff D, Hunter WC, Kass DA. Ventricular stroke work and efficiency both remain nearly optimal despite altered vascular loading. Am J Physiol. 1993;264: H1817-H1824.
29. Rooke GA, Feigl EO. Work as correlate of canine left ventricular oxygen consumption, and the problem of oxygen wasting. Circ Res. 1982;50:273-286.
30. Ishihara H, Yokota M, Sobue T, Saito H. Relation between ventriculoarterial coupling and myocardial energetics in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994;23: 406-416.
31. Schipke JD, Burkhoff D, Kass DA, Alexander J Jr, Schaefer J, Sagawa K. Hemodynamic dependence of myocardial oxygen consumption indexes. Am J Physiol. 1990;258:H1281-H1291.
32. Kass DA, Beyar R, Lankford EB, Heard M, Maughan WL, Sagawa K. Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations. Circulation. 1989;79:167-178.
33. Freeman GL, Little WC, O'Rourke RA. Influence of heart rate on left ventricular performance in conscious dogs. Circ Res. 1987;61: 455-464.
34. Liu CP, Lawrence W, Ting CT, Chang MS, Maughan WL, Kass DA. Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy: systolic versus diastolic determinants. Circulation. 1993;88:1893-1906.
35. Burstein S, Semigran MJ, Dec GW Jr, Boucher CA, Fifer MA. Positive inotropic and lusitropic effects of intravenous flosequinan in patients with heart failure. J Am Coll Cardial. 1992;20:822-829.
36. Herrmann HC, Ruddy TD, William G, Strauss HW, Boucher CA, Fifer MA. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol. 1987;9:1117-1123.
37. + channel blocking activity of the vesnarinone analog OPC-18790. Circulation. 1994; 90(suppl I):I-146. Abstract.
38. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure: dose-response relationships and comparison to nitroprusside. J Clin Invest. 1985;75:643-649.
39. Baim DS, McDowell AV, Cherniles J, Monrad ES, Parker JA, Edelson J, Braunwald E, Grossman W. Evaluation of a new bipyridine inotropic agent - milrinone - in patients with severe congestive heart failure. N Engl J Med. 1983;309:748-756.
40. Butterworth JF IV, Royster RL, Prielipp RC, Lawless ST, Wallenhaupt SL. Amrinone in cardiac surgical patients with left-ventricular dysfunction: a prospective, randomized placebo-controlled trial. Chest. 1993;104:1660-1667.
41. Itoh S, Mori T, Tominaga M, Ishikawa M, Koga K, Yabuuchi Y. Differential effects of OPC-18790, amrinone, and dobutamine on cardiac function and energy metabolism in the guinea-pig isolated ischaemic heart. Br J Pharmacol. 1995;114:1090-1096.
42. Feldman AM, Baughman KL, Lee WK, Gottlieb SH, Weiss JL, Becker LC, Strobeck JE. Usefulness of OPC-8212, a quinolinonc derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1991;68:1203-1210.
43. Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix GH, Powers ER, Bain RP, White BG. Effects of vesnarinone on morbidity and mortality in patients with heart failure: Vesnarinone Study Group. N Engl J Med. 1993;329:149-155.
44. Feldman AM, Strobeck JE. Quinolinone derivatives in the management of congestive heart failure. Coron Artery Dis. 1994;5: 107-111.
45. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, deMets DL, for the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE Study Research Group. N Engl J Med. 1991;325:1468-1475.
46. Wood MA, Hess ML. Long-term oral therapy of congestive heart failure with phosphodiesterase inhibitors. Am J Med Sci. 1989;297: 105-113.
47. Starling MR. Left ventricular-arterial coupling relations in the normal human heart. Am Heart J. 1993;125:1659-1666.
48. Ishizaka S, Asanoi H, Kameyama T, Sasayama S. Ventricular-load optimization by inotropic stimulation in patients with heart failure. Int J Cardiol. 1991;31:51-58.
49. Kameyama T, Asanoi H, Ishizaka S, Sasayama S. Ventricular load optimization by unloading therapy in patients with heart failure. J Am Coll Cardiol. 1991;17:199-207.
50. Kanda H, Ishihara H, Nagata K, Kato R, Sobue T, Yokota M. Beneficial effects of OPC-18790 on mechanoenergetics in patients with idiopathic dilated cardiomyopathy. Am J Coll Cardiol. 1995; 25:165A. Abstract.
51. Lankford EB, Kass DA, Maughan WL, Shoukas AA. Does volume catheter parallel conductance vary during a cardiac cycle? Am J Physiol. 1990;258:H1933-H1942.
52. Finnerty PW, Feldman MD, Wu CC, Subbiah K, Haber HL, Anne A, Skalak TC. Use of conductance catheter to determine left ventricular volume: current leakage beyond the left ventricular cavity. Proc Annu Int Conf IEEE Eng Med Biol Soc. 1993;15:903-904.
53. Kass DA, Marino PM, Maughan WL, Sagawa K. Determinants of end-systolic pressure-volume relations during acute regional ischemia in situ. Circulation. 1989;80:1783-1794.
54. Packer M, Medine N, Yushak M. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Circulation. 1985;71:761-766.